Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,387.60 +52.30 0.34%
S&P 500 1,669.16 +2.87 0.17%
Nasdaq 3,502.12 +5.69 0.16%
Ticker Volume Price Price Delta
STOXX 50 2,807.61 -14.04 -0.50%
FTSE 100 6,783.90 -19.97 -0.29%
DAX 8,438.01 -34.19 -0.40%
Ticker Volume Price Price Delta
Nikkei 15,627.30 +246.24 1.60%
Hang Seng 23,261.10 -105.29 -0.45%
S&P/ASX 200 5,165.37 -14.69 -0.28%

Odontoprev Slumps Most in 11 Weeks After Profit Misses Estimates

Odontoprev SA (ODPV3), a Brazilian dental benefits company, fell the most in 11 weeks after reporting fourth-quarter profit that missed analysts’ estimates.

Shares dropped 4.8 percent to 9.28 reais at 3:17 p.m. in Sao Paulo, the biggest one-day slump since Dec. 13. It was the main decliner in the Bovespa’s small-cap index, which gained 0.2 percent. Trading volume on the stock was 4.9 times the daily average over the past three months, according to data compiled by Bloomberg.

Odontoprev’s adjusted net income was 27.1 million reais ($13.7 million) in the fourth quarter, data compiled by Bloomberg after the company released results yesterday shows. The average estimate of eight analysts was 42.1 million reais.

“As the cost-related miss seems structural, the fourth quarter could have more serious implications for future years, potentially driving strong downward revisions,” Banco BTG Pactual SA’s analysts Joao Carlos Santos and Pedro Montenegro wrote in a research note to clients today, calling the results “dismal.”

Santos and Montenegro reiterated their sell rating on the stock. Josh Milberg, an analyst at Deutsche Bank AG, cut Odontoprev to sell from hold and reduced the target price 26 percent to 8.5 reais today.

The Barueri, Brazil-based company’s shares have dropped 18 percent since reaching this year’s high on Jan. 7, while the Bovespa benchmark index has fallen 7.9 percent in the same period.

To contact the reporter on this story: Julia Leite in New York at jleite3@bloomberg.net

To contact the editor responsible for this story: David Papadopoulos at papadopoulos@bloomberg.net

Bloomberg moderates all comments. Comments that are abusive or off-topic will not be posted to the site. Excessively long comments may be moderated as well. Bloomberg cannot facilitate requests to remove comments or explain individual moderation decisions.

Sponsored Link